Table:
begin	end	state
1	27	cytoplasmic
28	51	transmembrane
52	64	non-cytoplasmic
65	84	transmembrane
85	95	cytoplasmic
96	115	transmembrane
116	120	non-cytoplasmic
121	143	transmembrane
144	154	cytoplasmic
155	178	transmembrane
179	183	non-cytoplasmic
184	205	transmembrane
206	262	cytoplasmic
263	282	transmembrane
283	293	non-cytoplasmic
294	317	transmembrane
318	326	cytoplasmic
327	347	transmembrane
348	352	non-cytoplasmic
353	376	transmembrane
377	387	cytoplasmic
388	412	transmembrane
413	417	non-cytoplasmic
418	438	transmembrane
439	447	cytoplasmic

Input:
>HSERO_RS05600
MSIHTSGALPTVHVDQVVEQGRFGAFQFGLLLLCGLCLIIDGFDVQAMGYVAPAIIADWG
VSKASLGPVFGAGLFGMLLGSLVLTPVGDRYGRRPVLILSTLFFALCMLATPMVTTLDQL
LVLRFITGFGLGSIMPNAMALVGEFSPSSSRVTRMMLVSCGFTVGAAAGGFVSAALIPAY
GWHAVFWVGGAVPLVLGLAMLVWLPESIQFLVLHRRPRTQVARWLRKLDPNIVIDDKTEV
VVKETKAEGMPVAALFRDGRAGVTVLLWLISFMNLINLYFLSNWLPTLIRDAGYSTSMAV
LIGTSLQVGGVIGTLSLGRFIQRFGFTRVLGSCFLLACLSIALIGKLATVPALLFVAVIV
AGFCIVGGQPAVNALAGTFYPTTLRSTGIGWALGIGRIGSVVGPVIGGQLIALQWTNASL
FLAAAVPALISALTIARLHRTAQGVSA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server